Hence, a study in NSCLC cell lines harboring EGFR wild type has shown that gefitinib promotes autophagy and apoptosis, leading to lung cancer cell death, via blockade of the PI3K/AKT/mTOR pathway [40]. Here, AKT1 is linked to lung cancer.